Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Ahrensburg – page 120

1 437 clinical trials in Ahrensburg, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Ahrensburg at a glance
1 437
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

1 437 trials in Ahrensburg

Open in trial search

Study on Imatinib and Chemotherapy Combination for Children with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years
  • Substances:Crisantaspase
  • Sponsor:Universita Degli Studi Di Milano Bicocca

Study on Additional Chemotherapy with Osimertinib, Carboplatin, and Cisplatin for Patients with Advanced Non-Small Cell Lung Cancer and EGFR Mutation

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Goethe University Frankfurt

Asthma

Not recruiting

Study on Reducing Asthma Medication with Tezepelumab in Patients Aged 12 to 80 with Severe Asthma

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Tezepelumab
  • Sponsor:AstraZeneca AB

Crohn's disease

Not recruiting

Study on Guselkumab for Healing in Crohn's Disease Patients

InvestigationalNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Guselkumab
  • Sponsor:Janssen Cilag International

Study on Datopotamab Deruxtecan and Osimertinib for Patients with Advanced Non-Small Cell Lung Cancer After Osimertinib Treatment

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:AstraZeneca AB

Study on Ibrutinib and Drug Combination for Patients with Generalized Mantle Cell Lymphoma

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years
  • Substances:Ibrutinib
  • Sponsor:Klinikum Der Universitat Munchen AöR

Study on Evolocumab for Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years
  • Substances:Evolocumab
  • Sponsor:Assistance Publique Hopitaux De Paris

Study on EYE103 and Ranibizumab for Patients with Diabetic Macular Edema

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:EYE103
  • Sponsor:Eyebiotech Limited

Colitis ulcerative

Not recruiting

Study of RO7790121 Compared to Placebo for Treatment of Adults with Moderate to Severe Ulcerative Colitis

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:RO7790121
  • Sponsor:F. Hoffmann-La Roche AG

Other cities in Germany

The busiest research cities in the country

All 505 cities in Germany

Clinical research in Ahrensburg

What the registry says about research in the country

01 Respiratory Diseases

Innovative research focusing on asthma management and treatment, particularly examining new therapeutic approaches for patients with uncontrolled conditions. Studies are evaluating novel compounds to reduce exacerbation risks and improve symptom control.

  • Uncontrolled Asthma Studies
  • Gene Expression Analysis
  • Treatment Safety Evaluation

Multiple trials investigating both established and experimental treatments to enhance respiratory function and quality of life.

02 Pulmonary Conditions

Comprehensive studies addressing COPD and bronchiectasis, investigating new treatment modalities and their effects on exercise parameters and pulmonary function. Research includes assessment of dynamic hyperinflation and inflammatory responses.

  • Bronchiectasis Management
  • COPD Treatment Innovation
  • Exercise Performance Studies

Focus on developing targeted therapies for chronic respiratory conditions.

03 Specialized Respiratory Care

Advanced research into pulmonary fibrosis and allergic conditions, including long-term treatment evaluations and immunotherapy approaches. Studies examine safety profiles and efficacy of new therapeutic agents.

  • Pulmonary Fibrosis Treatments
  • Allergic Rhinitis Studies
  • Immunotherapy Research

Investigating innovative solutions for complex respiratory conditions requiring specialized care.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.